5to6: Difference between revisions

No edit summary
No edit summary
 
Line 3: Line 3:
<StructureSection load='5to6' size='340' side='right'caption='[[5to6]], [[Resolution|resolution]] 2.70&Aring;' scene=''>
<StructureSection load='5to6' size='340' side='right'caption='[[5to6]], [[Resolution|resolution]] 2.70&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[5to6]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5TO6 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5TO6 FirstGlance]. <br>
<table><tr><td colspan='2'>[[5to6]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5TO6 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5TO6 FirstGlance]. <br>
</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5to5|5to5]], [[5to7|5to7]]</td></tr>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.7&#8491;</td></tr>
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">TPR ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5to6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5to6 OCA], [https://pdbe.org/5to6 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5to6 RCSB], [https://www.ebi.ac.uk/pdbsum/5to6 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5to6 ProSAT]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5to6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5to6 OCA], [http://pdbe.org/5to6 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5to6 RCSB], [http://www.ebi.ac.uk/pdbsum/5to6 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5to6 ProSAT]</span></td></tr>
</table>
</table>
== Disease ==
== Disease ==
[[http://www.uniprot.org/uniprot/TPR_HUMAN TPR_HUMAN]] Papillary or follicular thyroid carcinoma. A chromosomal aberration involving TPR has been found in papillary thyroid carcinomas (PTCs). Intrachromosomal rearrangement that links the 5'-end of the TPR gene to the protein kinase domain of NTRK1 forms the fusion protein TRK-T1. TRK-T1 is a 55 kDa protein reacting with antibodies against the carboxy terminus of the NTRK1 protein.<ref>PMID:1532241</ref>  Involved in tumorigenic rearrangements with the MET.<ref>PMID:2300559</ref>
[https://www.uniprot.org/uniprot/TPR_HUMAN TPR_HUMAN] Papillary or follicular thyroid carcinoma. A chromosomal aberration involving TPR has been found in papillary thyroid carcinomas (PTCs). Intrachromosomal rearrangement that links the 5'-end of the TPR gene to the protein kinase domain of NTRK1 forms the fusion protein TRK-T1. TRK-T1 is a 55 kDa protein reacting with antibodies against the carboxy terminus of the NTRK1 protein.<ref>PMID:1532241</ref>  Involved in tumorigenic rearrangements with the MET.<ref>PMID:2300559</ref>  
== Function ==
== Function ==
[[http://www.uniprot.org/uniprot/TPR_HUMAN TPR_HUMAN]] Component of the nuclear pore complex (NPC), a complex required for the trafficking across the nuclear envelope. Functions as a scaffolding element in the nuclear phase of the NPC essential for normal nucleocytoplasmic transport of proteins and mRNAs, plays a role in the establishment of nuclear-peripheral chromatin compartmentalization in interphase, and in the mitotic spindle checkpoint signaling during mitosis. Involved in the quality control and retention of unspliced mRNAs in the nucleus; in association with NUP153, regulates the nuclear export of unspliced mRNA species bearing constitutive transport element (CTE) in a NXF1- and KHDRBS1-independent manner. Negatively regulates both the association of CTE-containing mRNA with large polyribosomes and translation initiation. Does not play any role in Rev response element (RRE)-mediated export of unspliced mRNAs. Implicated in nuclear export of mRNAs transcribed from heat shock gene promoters; associates both with chromatin in the HSP70 promoter and with mRNAs transcribed from this promoter under stress-induced conditions. Modulates the nucleocytoplasmic transport of activated MAPK1/ERK2 and huntingtin/HTT and may serve as a docking site for the XPO1/CRM1-mediated nuclear export complex. According to some authors, plays a limited role in the regulation of nuclear protein export (PubMed:22253824 and PubMed:11952838). Plays also a role as a structural and functional element of the perinuclear chromatin distribution; involved in the formation and/or maintenance of NPC-associated perinuclear heterochromatin exclusion zones (HEZs). Finally, acts as a spatial regulator of the spindle-assembly checkpoint (SAC) response ensuring a timely and effective recruitment of spindle checkpoint proteins like MAD1L1 and MAD2L1 to unattached kinetochore during the metaphase-anaphase transition before chromosome congression. Its N-terminus is involved in activation of oncogenic kinases.<ref>PMID:11952838</ref> <ref>PMID:15654337</ref> <ref>PMID:17897941</ref> <ref>PMID:18794356</ref> <ref>PMID:18981471</ref> <ref>PMID:19273613</ref> <ref>PMID:20133940</ref> <ref>PMID:20407419</ref> <ref>PMID:21613532</ref> <ref>PMID:22253824</ref> <ref>PMID:9864356</ref>
[https://www.uniprot.org/uniprot/TPR_HUMAN TPR_HUMAN] Component of the nuclear pore complex (NPC), a complex required for the trafficking across the nuclear envelope. Functions as a scaffolding element in the nuclear phase of the NPC essential for normal nucleocytoplasmic transport of proteins and mRNAs, plays a role in the establishment of nuclear-peripheral chromatin compartmentalization in interphase, and in the mitotic spindle checkpoint signaling during mitosis. Involved in the quality control and retention of unspliced mRNAs in the nucleus; in association with NUP153, regulates the nuclear export of unspliced mRNA species bearing constitutive transport element (CTE) in a NXF1- and KHDRBS1-independent manner. Negatively regulates both the association of CTE-containing mRNA with large polyribosomes and translation initiation. Does not play any role in Rev response element (RRE)-mediated export of unspliced mRNAs. Implicated in nuclear export of mRNAs transcribed from heat shock gene promoters; associates both with chromatin in the HSP70 promoter and with mRNAs transcribed from this promoter under stress-induced conditions. Modulates the nucleocytoplasmic transport of activated MAPK1/ERK2 and huntingtin/HTT and may serve as a docking site for the XPO1/CRM1-mediated nuclear export complex. According to some authors, plays a limited role in the regulation of nuclear protein export (PubMed:22253824 and PubMed:11952838). Plays also a role as a structural and functional element of the perinuclear chromatin distribution; involved in the formation and/or maintenance of NPC-associated perinuclear heterochromatin exclusion zones (HEZs). Finally, acts as a spatial regulator of the spindle-assembly checkpoint (SAC) response ensuring a timely and effective recruitment of spindle checkpoint proteins like MAD1L1 and MAD2L1 to unattached kinetochore during the metaphase-anaphase transition before chromosome congression. Its N-terminus is involved in activation of oncogenic kinases.<ref>PMID:11952838</ref> <ref>PMID:15654337</ref> <ref>PMID:17897941</ref> <ref>PMID:18794356</ref> <ref>PMID:18981471</ref> <ref>PMID:19273613</ref> <ref>PMID:20133940</ref> <ref>PMID:20407419</ref> <ref>PMID:21613532</ref> <ref>PMID:22253824</ref> <ref>PMID:9864356</ref>  
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 21: Line 20:
</div>
</div>
<div class="pdbe-citations 5to6" style="background-color:#fffaf0;"></div>
<div class="pdbe-citations 5to6" style="background-color:#fffaf0;"></div>
==See Also==
*[[Nucleoprotein 3D structures|Nucleoprotein 3D structures]]
== References ==
== References ==
<references/>
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Human]]
[[Category: Homo sapiens]]
[[Category: Large Structures]]
[[Category: Large Structures]]
[[Category: Bandyopadhyay, A]]
[[Category: Bandyopadhyay A]]
[[Category: Melcher, K]]
[[Category: Melcher K]]
[[Category: Pal, K]]
[[Category: Pal K]]
[[Category: Xu, H E]]
[[Category: Xu HE]]
[[Category: Xu, Q]]
[[Category: Xu Q]]
[[Category: Zhou, X E]]
[[Category: Zhou XE]]
[[Category: Cell cycle]]
[[Category: Met]]
[[Category: Oncogenic fusion kinase]]
[[Category: Receptor tyrosine kinase]]
[[Category: Tpr oligomerization domain]]

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA